Morgan Dempsey Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-309
Closed -$53K 137
2020
Q3
$53K Sell
309
-206
-40% -$38K 0.02% 82
2020
Q2
$99K Sell
515
-53
-9% -$8.67K 0.04% 58
2020
Q1
$84K Sell
568
-9
-2% -$1.43K 0.04% 58
2019
Q4
$89K Sell
577
-25
-4% -$3.6K 0.04% 101
2019
Q3
$81K Hold
602
0.03% 116
2019
Q2
$73K Hold
602
0.03% 121
2019
Q1
$63K Hold
602
0.03% 125
2018
Q4
$69K Sell
602
-15
-2% -$1.61K 0.03% 130
2018
Q3
$71K Hold
617
0.03% 126
2018
Q2
$64K Sell
617
-160
-21% -$16.2K 0.03% 130
2018
Q1
$76.5K Sell
777
-41
-5% -$3.87K 0.03% 130
2017
Q4
$69.3K Hold
818
0.02% 134
2017
Q3
$63K Sell
818
-1,321
-62% -$101K 0.02% 129
2017
Q2
$167K Sell
2,139
-50
-2% -$3.58K 0.06% 117
2017
Q1
$158K Buy
2,189
+50
+2% +$3.46K 0.06% 115
2016
Q4
$133K Sell
2,139
-51
-2% -$3.12K 0.04% 120
2016
Q3
$142K Hold
2,190
0.05% 118
2016
Q2
$138K Hold
2,190
0.05% 117
2016
Q1
$127K Sell
2,190
-148
-6% -$8.38K 0.05% 116
2015
Q4
$126K Hold
2,338
0.05% 125
2015
Q3
$119K Sell
2,338
-602
-20% -$32.4K 0.04% 122
2015
Q2
$166K Hold
2,940
0.05% 122
2015
Q1
$211K Hold
2,940
0.06% 120
2014
Q4
$165K Sell
2,940
-346
-11% -$18.1K 0.04% 130
2014
Q3
$162K Buy
3,286
+346
+12% +$17.6K 0.04% 135
2014
Q2
$149K Hold
2,940
0.03% 134
2014
Q1
$131K Hold
2,940
0.03% 141
2013
Q4
$138K Sell
2,940
-1,270
-30% -$64.3K 0.04% 139
2013
Q3
$222K Sell
4,210
-3,165
-43% -$154K 0.08% 116
2013
Q2
$333K Buy
+7,375
New +$350K 0.13% 110

Other funds holding RMD

Morgan Dempsey Capital Management's RMD Position: Q4 2020 in Review

Morgan Dempsey Capital Management sold out of ResMed (RMD) in Q4 2020, closing a stake of 309 shares — an estimated $53K sold.

Morgan Dempsey Capital Management first reported a position in RMD in Q2 2013 and held it in 30 quarters. The position peaked at $333K in Q2 2013. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Morgan Dempsey Capital Management reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Morgan Dempsey Capital Management sold 309 ResMed shares in Q4 2020, an estimated $53K.
  • Morgan Dempsey Capital Management first reported a position in ResMed in Q2 2013 and held it in 30 quarters.
  • Morgan Dempsey Capital Management's ResMed position peaked at $333K in Q2 2013.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Morgan Dempsey Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.